2007
DOI: 10.4103/0250-474x.39448
|View full text |Cite
|
Sign up to set email alerts
|

Orodispersible tablets of meloxicam using disintegrant blends for improved efficacy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
11
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 0 publications
1
11
0
Order By: Relevance
“…This negative effect may be due to the formation of a viscous gel layer by CCS and SSG which may impede further penetration of the disintegration medium and hindered the disintegration of tablets. 24,25) The obtained results were similar to the findings of Khan et al 26) and Patel et al…”
Section: Effect Of Type and Concentration Of Superdisintegrantsupporting
confidence: 90%
“…This negative effect may be due to the formation of a viscous gel layer by CCS and SSG which may impede further penetration of the disintegration medium and hindered the disintegration of tablets. 24,25) The obtained results were similar to the findings of Khan et al 26) and Patel et al…”
Section: Effect Of Type and Concentration Of Superdisintegrantsupporting
confidence: 90%
“…On the contrary, when the concentration of CCS and SSG was increased, it had a negative effect on the disintegration of the tablets. This negative effect may be due to the formation of a viscous gel layer by CCS and SSG which may impede further penetration of the disintegration medium and hinder the disintegration of tablet contents (Swamy et al, 2007;Setty et al, 2008). Moreover, at the same concentration level, the disintegration time of the tablets formulated using crospovidone was lower than those containing CCS and SSG.…”
Section: In Vitro Disintegration Timementioning
confidence: 96%
“…Their major advantage is that they can be taken without water at any time, which is ideal for pediatric and geriatric patients. Further, increased bioavailability and good stability make ODTs the dosage form of choice in the current market (Swamy et al, 2007;Patel and Patel, 2008). From the perspective of industry, ODTs may provide new business opportunities in the form of product differentiation, patent life extension and cost effective drug development (Battu et al, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…Drug content for ORD tablet was done by the assay method. 15,16 First the prepared tablet (2 mg API) was crushed and added to 10 ml of phosphate buffer pH 6.8. After 30 min the solution was filtered 17 and from 10 ml solution 1ml solution was withdrawn diluted up to 20 ml with phosphate buffer pH 6.8(10 µg/ml).…”
Section: Drug Contentmentioning
confidence: 99%